The next generation of spingolipid stars

Archives of Biochemistry and Biophysics

Volumn 419, Issue 2, 2003, Pages 99-100

  Kester, Mark ^a   Obeid, Lina M ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; FINGOLIMOD; MEMBRANE LIPID; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOSINE 1 PHOSPHATE;

CELL FUNCTION; CHEMICAL ANALYSIS; DRUG POTENCY; EDITORIAL; HUMAN; LIPID MEMBRANE; MEDICAL RESEARCH; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; SECOND MESSENGER;

EID: 0142258008     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9861(03)00547-2     Document Type: Editorial

References (15)

1. Kester M., Kolesnick R. Pharmacological Res. 47:2003;365-371.
2. Kolesnick R. J. Clin. Invest. 110:2002;3-8.
3. Y.A. Hannun, L.M. Obeid, J. Biol. Chem. 277 (2002) 25847-2550.
4. Mandala S., Hajdu R., Bergstrom J.et al. Science. 296:2002;346-349.
5. Brinkmann V., Davis M.D., Heise C.E.et al. J. Biol. Chem. 277:2002;21453-21457.
6. Budde K., Schmouder R.L., Brunkhorst R.et al. J. Am. Soc. Nephrol. 13:2002;1073-1083.
7. Paris F., Perezx G.I., Fuks Z.et al. Natl. Med. 8:2002;901-902.
8. Furuya K., Ginis I., Takeda H., Chen Y., Hallenbrook J.M. J. Cereb. Blood Flow Metab. 21:2001;226-232.
9. Charles R., Sandirasegarane L., Yun J.et al. Circ. Res. 87:2000;282-288.
10. P.L. DeSouza, available at: http//www.novogen.com/pharma/pharma041.cfm? mainsection=04&subsection=03#04.
11. Schwartz G.K., Ward D., Saltz L.et al. Clin. Cancer Res. 3:1997;537-543.
12. Brady R.O. Philos. Trans. Royal Soc. London. 358:2003;915-919.
13. Acharya U., Patel S., Koundakjian E., Nagashima K., Han X., Acharya J.K. Science. 299:2002;1740-1743.
14. T. Stover, M. Kester, J. Pharm. Exp. Ther. (2003) in press.
15. Shabbits J., Mayer L. Biochim. Biophys. Acta. 1612:2003;98-106.